Smokers with HIV doing well on treatment now at greater risk of lung cancer than AIDS
San Francisco annual report shows continued drop in new HIV infections
What are the barriers to HIV testing and treatment access – and how do we overcome them?
High prices of DAAs mean there's been little progress towards achieving WHO target of eliminating HCV by 2030
Study documents changing opinion among Italian doctors about PrEP
New guidelines recommend that women avoid tenofovir & emtricitabine during pregnancy
New US PrEP cost-effectiveness model finds drug prices will need to drop substantially if HIV risk rises, or if adherence is only moderate
Maraviroc matches boosted protease inhibitor treatment over 96 weeks
What's going on in gay men’s lives when they acquire HIV?
